↓ Skip to main content

A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)

Overview of attention for article published in BMC Cancer, December 2022
Altmetric Badge

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)
Published in
BMC Cancer, December 2022
DOI 10.1186/s12885-022-10443-4
Pubmed ID
Authors

Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, Manuel Bardiès, Lore Santoro, Sophie Gourgou

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 15%
Student > Doctoral Student 2 15%
Unspecified 1 8%
Student > Bachelor 1 8%
Student > Ph. D. Student 1 8%
Other 1 8%
Unknown 5 38%
Readers by discipline Count As %
Nursing and Health Professions 2 15%
Biochemistry, Genetics and Molecular Biology 2 15%
Medicine and Dentistry 2 15%
Unspecified 1 8%
Engineering 1 8%
Other 0 0%
Unknown 5 38%